# Sight Sciences to Present at the 25th Annual Needham Healthcare Conference on April 13th
Canonical URL: https://biopharmsignal.com/news/SGHT/sight-sciences-to-present-at-the-25th-annual-needham-healthcare-conference-on-april-13th
Ticker: SGHT
Company: Sight Sciences
Source: Sight Sciences
Published: 2026-03-30 20:05 EST
Original Source URL: https://investors.sightsciences.com
## Summary

MENLO PARK, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives,

## Article Body
MENLO PARK, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives,
## Recent Company News
- 2026-05-06 20:05 EST — [Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance](https://biopharmsignal.com/news/SGHT/sight-sciences-reports-first-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance) — Source: Sight Sciences
- 2026-04-29 20:05 EST — [Sight Sciences to Present at Two Upcoming Investor Conferences](https://biopharmsignal.com/news/SGHT/sight-sciences-to-present-at-two-upcoming-investor-conferences) — Source: Sight Sciences
- 2026-04-22 20:45 EST — [Sight Sciences Announces the Release of its Sustainability Report](https://biopharmsignal.com/news/SGHT/sight-sciences-announces-the-release-of-its-sustainability-report) — Source: Sight Sciences
- 2026-04-21 20:05 EST — [Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026](https://biopharmsignal.com/news/SGHT/sight-sciences-to-report-first-quarter-2026-financial-results-on-may-6-2026) — Source: Sight Sciences
- 2026-04-01 20:05 EST — [Sight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting](https://biopharmsignal.com/news/SGHT/sight-sciences-interventional-technologies-for-glaucoma-and-dry-eye-disease-to-be-featured-in-multiple-clinical-presentations-at-the-2026-american-society-of-cataract-and-refractive-surgery-ascrs-annual-meeting) — Source: Sight Sciences
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)